EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7
Source abstract
Abstract
In the present study, the application of mesoporous silica nanoparticles (MSNPs) loaded with recombinant EspA protein, an immunogen of enterohaemorrhagic E. coli, was investigated in the case of BALB/c mice immunization against the bacterium. MSNPs of 96.9 ± 15.9 nm in diameter were synthesized using template removing method. The immunization of mice was carried out orally and subcutaneously. Significant immune responses to the antigen were observed for the immunized mice when rEspA-loaded MSNPs were administered in both routes in comparison to that of the antigen formulated using a well-known adjuvant, i.e. Freund's. According to the titretitre of serum IL-4, the most potent humoral responses were observed when the mice were immunized subcutaneously with antigen-loaded MSNPs (244, 36 and 14 ng/dL of IL-4 in the serum of mice immunized subcutaneously or orally by antigen-loaded MSNPs, and subcutaneously by Freund's adjuvant formulated-antigen, respectively). However, the difference in serum IgG and serum IgA was not significant in mice subcutaneously immunized with antigen-loaded MSNPs and mice immunized with Freund's adjuvant formulated-antigen. Finally, the immunized mice were challenged orally by enterohaemorrhagic E. coli cells. The amount of bacterial shedding was significantly reduced in faecesfaeces of the animals immunized by antigen-loaded MSNPs in both subcutaneous and oral routes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Escherichia coli research studies · Viral gastroenteritis research and epidemiology · Bacteriophages and microbial interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Applied Biotechnology Research Centre, Baqiyatallah University of Medical Sciences
Agriculture Biotechnology Department, National Institute for Genetic Engineering and Biotechnology
Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences
Biology Research Centre
, Imam Hossein University
Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology
References (46)
Show source-provided references
1. 10.1038/sj.clpt.610040010.1038/sj.clpt.6100400 ↗
2. Hajizade AF, Ebrahimi A-H, Salmanian A, et al. Nanoparticles in vaccine development. J Appl Biotechnol Rep 2015;1:125–134.
3. 10.1002/jcb.2079610.1002/jcb.20796 ↗
4. 10.2217/nnm-2017-001510.2217/nnm-2017-0015 ↗
5. 10.1016/j.csbj.2015.11.00110.1016/j.csbj.2015.11.001 ↗
6. 10.1016/j.vaccine.2013.11.06910.1016/j.vaccine.2013.11.069 ↗
7. 10.1016/j.biomaterials.2014.10.04310.1016/j.biomaterials.2014.10.043 ↗
8. Tiyaboonchai W. Chitosan nanoparticles: a promising system for drug delivery. วรสารมหาาวทยาลย นเรศวร (Naresuan Univ J) 2013;11:51–66.
9. 10.1016/j.jconrel.2015.04.01010.1016/j.jconrel.2015.04.010 ↗
10. 10.1016/j.vaccine.2015.10.13210.1016/j.vaccine.2015.10.132 ↗
11. 10.1016/j.addr.2014.10.02310.1016/j.addr.2014.10.023 ↗
12. 10.1093/infdis/jiu33710.1093/infdis/jiu337 ↗
13. 10.1016/j.jconrel.2015.03.00210.1016/j.jconrel.2015.03.002 ↗
14. 10.1016/j.antiviral.2016.03.00510.1016/j.antiviral.2016.03.005 ↗
15. 10.1021/nn305700510.1021/nn3057005 ↗
16. 10.7150/thno.1510210.7150/thno.15102 ↗
17. 10.1038/nri286810.1038/nri2868 ↗
18. 10.1021/ja071978010.1021/ja0719780 ↗
19. 10.1021/tx300166u10.1021/tx300166u ↗
20. 10.1016/j.cej.2007.09.04510.1016/j.cej.2007.09.045 ↗
21. 10.7150/thno.1138910.7150/thno.11389 ↗
22. 10.1097/01.mop.0000152997.66070.e910.1097/01.mop.0000152997.66070.e9 ↗
23. Karch H, Mellmann A, Bielaszewska M. Epidemiology and pathogenesis of enterohaemorrhagic Escherichia coli. Berliner Und Munchener Tierarztliche Wochenschrift 2008;122:417–424.
24. 10.1128/IAI.68.9.5090-5095.200010.1128/IAI.68.9.5090-5095.2000 ↗
25. 10.1073/pnas.091507710710.1073/pnas.0915077107 ↗
26. 10.1128/IAI.73.10.6523-6529.200510.1128/IAI.73.10.6523-6529.2005 ↗
27. 10.1016/j.micinf.2009.04.02410.1016/j.micinf.2009.04.024 ↗
28. 10.21786/bbrc/9.1/910.21786/bbrc/9.1/9 ↗
29. 10.1093/emboj/17.8.216610.1093/emboj/17.8.2166 ↗
30. 10.1046/j.1365-2958.1998.01046.x10.1046/j.1365-2958.1998.01046.x ↗
31. 10.1099/0022-1317-49-1-9710.1099/0022-1317-49-1-97 ↗
32. 10.1002/smll.20130001210.1002/smll.201300012 ↗
33. 10.1021/acsami.6b1132410.1021/acsami.6b11324 ↗
34. 10.4103/1947-2714.10099810.4103/1947-2714.100998 ↗
35. 10.1039/C5RA08405A10.1039/C5RA08405A ↗
36. 10.14227/DT180311P1510.14227/DT180311P15 ↗
37. 10.1128/CDLI.11.5.841-848.200410.1128/CDLI.11.5.841-848.2004 ↗
38. 10.1136/jcp.31.6.50710.1136/jcp.31.6.507 ↗
39. 10.1016/S0022-1759(98)00170-710.1016/S0022-1759(98)00170-7 ↗
40. 10.1016/j.actatropica.2013.04.00210.1016/j.actatropica.2013.04.002 ↗
41. 10.1128/IAI.72.1.168-175.200410.1128/IAI.72.1.168-175.2004 ↗
42. 10.1093/nar/19.22.633710.1093/nar/19.22.6337 ↗
43. 10.1016/j.ejps.2010.07.00410.1016/j.ejps.2010.07.004 ↗
44. 10.1016/j.ymeth.2006.05.01610.1016/j.ymeth.2006.05.016 ↗
45. 10.3390/info601001410.3390/info6010014 ↗
46. 10.1186/1743-8977-9-310.1186/1743-8977-9-3 ↗